Endocrine, Metabolic and Immune Disorders - Drug Targets : Impact Factor & More

eISSN: 2212-3873pISSN: 1871-5303

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Endocrine, Metabolic and Immune Disorders - Drug Targets Key Metrics

CiteScore
3.8
Impact Factor
< 5
SNIP
0.7

Endocrine, Metabolic and Immune Disorders - Drug Targets Journal Specifications

Overview
Publisher BENTHAM SCIENCE PUBL LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2001
Publisher URLVisit website
Website URLVisit website
View less
NEW

Submissions Pack

Expert Services + AI tools

One subscription packed with expert publication services and AI tools to get you published

Brought to you by
  • Journal Selection Service

    Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.

  • Journal Submission Service

    Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission

Bundle of AI tools for your research needs

Journal Finder, Paperpal, R Discovery, MindTheGraph and more

View benefits in detail

Buy now for a special Launch price!

$199
$249

Planning to publish in Endocrine, Metabolic and Immune Disorders - Drug Targets ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Endocrine, Metabolic and Immune Disorders - Drug Targets

Check if your research matches the topics covered in Endocrine, Metabolic and Immune Disorders - Drug Targets?

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Check your research

FAQs on Endocrine, Metabolic and Immune Disorders - Drug Targets

How long has Endocrine, Metabolic and Immune Disorders - Drug Targets been actively publishing? Faqs

Endocrine, Metabolic and Immune Disorders - Drug Targets has been in operation since 2001 till date.

What is the publishing frequency of Endocrine, Metabolic and Immune Disorders - Drug Targets? Faqs

Endocrine, Metabolic and Immune Disorders - Drug Targets published with a Bi-monthly frequency.

How many articles did Endocrine, Metabolic and Immune Disorders - Drug Targets publish last year? Faqs

In 2023, Endocrine, Metabolic and Immune Disorders - Drug Targets publsihed 13 articles.

What is the eISSN & pISSN for Endocrine, Metabolic and Immune Disorders - Drug Targets? Faqs

For Endocrine, Metabolic and Immune Disorders - Drug Targets, eISSN is 2212-3873 and pISSN is 1871-5303.

What is Citescore for Endocrine, Metabolic and Immune Disorders - Drug Targets? Faqs

Citescore for Endocrine, Metabolic and Immune Disorders - Drug Targets is 3.8.

What is SNIP score for Endocrine, Metabolic and Immune Disorders - Drug Targets? Faqs

SNIP score for Endocrine, Metabolic and Immune Disorders - Drug Targets is 0.7.

Who is the publisher of Endocrine, Metabolic and Immune Disorders - Drug Targets? Faqs

BENTHAM SCIENCE PUBL LTD is the publisher of Endocrine, Metabolic and Immune Disorders - Drug Targets.